Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Rops2g01155 | ATGCTGCTATCTAGGACCTTCTTTGCTTTCTTAATCATAGCATTGAGTTATTGTTTCACATGGCTTGAATATGCTGAATCCAAACTACCCCAGGAAGAGGTTAATGCTCTTGAAGAAATCACTAGAACGATGGGTGCCACCTATTGGAAGTTTGATAGTGATTCTTGTCAAATTGAAATGGTTGGGTTAACACCAAAGCGACCTGATGGATCTCAAAGCAGCATTGATTGTGATTGCTCTTCTGAAAAAGACACCTTCTGTCATGTAGTAAGGATTATGTTCAAGGGGTACAACCTTCCTGGCATGCTTCCTCCTGAAATGGTTAAGCTTCCTTACCTCAGAGAAATTGATTTAGCATTAAATTACCTAAATGGTACGATCCCAAAGGAATGGGCTTCAATGAAACTAACTTCAATCTCTCTATTTGTTAATCGTTTATCAGGGGAAATTCCTAAGGAGTTGGGAAATATTACCACTCTAACATACCTGAACCTTGAAGCAAACCAATTTTCTGGTCTTGTTCCCTCTGAACTTGGAAGTCTATTTGACCTGCAAACTTTGATTTTATCATCCAATAAATTGTCTGGGAACTTACCTGTGACATTTGCTCAGTTACAGAATTTGACAGATTTTAGGATAAATGATAACAGTTTCAAAGGAAAAATACCTAGCTTCATACAGAATTGGAAACAACTTCAAAGACTAGAAATGCTTGGAAGTGGACTGGAGGGACCTATCCCATCAAATATATCTCTTTTGAGTAATTTATCTCAACTGAGGATTAGTGACATAAATGGTCCAAGTCAGGATTTTCCTATTTTAAGCAATATGACGGGAATGATAAGATTGATTTTGAGAAATTGTAATATTACCGGCGAGCTTCCTAGCTACTTCTGGACAATGAAGAGTTTGGAAATGTTGGATCTCAGCTTCAATAATTTGGTTGGGGAAATACCCGTGACCGTGATGGTACATGTGGGGCATTTGAGATTTCTCTTCCTAACTGGCAACATGCTAAGTGGTAATGTACCAGACTCTGTCTTGATGGATGGAAGCAATGTTGATCTTTCTTACAACAACTTTACGTGGCAAGGAGCTGAGCAATCTGCTTGTGGAGATTACCTGAATTTAAACCTAAACTTGTTCCGAAGCTCTGTAGGGACAAATGCATTACAGGGGATTCTTCCATGTTTAAAAACTTTCAACTGTCCTAGATATTCAAGTTGTTTGCATGTTAATTGTGGTGGAAAGGATATAAAGGTGACGGAAAATGATGAAGATGTCCTCTATGTAGGAGATGGAGATGTGGTAGGTGGTGCTGCTAAATATTTTAATGATTATAAAAATTACTGGGGGTTTAGTAGCACTGGGGACTTCCTGGATGATGGTGATTACCAAAATACACGTTACACCAGGTCTTTGTCATCTTCAAGCATGCCTGAATTATATACAACGGCTCGTGTCTCTCCGATTTCACTTACTTATTTTCACTATTGCTTGGAAAATGGGAAATATACTGTAAATCTCCACTTTGCAGAAATACAATTTACAAATGATAACACATATAAAAGTCTTGGGAAGCGCGTATTTGATATCTATGTTCAGGAAAGATTAGTTTGGAAGGATTTTAATATTGAAGATGAAACACATGTTGCTCAAAAACTACGTATAATATCAATATATAATGTCACTGTAACAGACAATATTCTGGAGATTCGATTCTACTGGGCTGGCAAGGGGACTACAAGGATTCCTGTTGCTGGAGTTTATGGTCCCCTCATTTCAGCTTTCTCTGTTGTTTCTGATTCTAAACCTTGTTCAGACCGAACAAACGGAAGGCGTAAAATAATCGTTGGAGTTGGATTTGGGGTTGGAGCTCTATGCCTAGTCATTATTGTAGTGGGAATCTGTTGGTGGAAAGGCTACATCAAAGGAATAATTAGAAGAGAAAAAGGTATTGAAGGGCAAGAGTCTCATATGAGGACATTTACATTAAAACAAATTAGCACTGCCACAGATGACTTCAGTCCTGCTAACAAGATTGGGGAAGGTGGTTTTGGTCCTGTCTACAAGGGTCAATTATCTGATGGTACATGGGTAGCAGTCAAACAGCTATCATCAAAGTCCCGGCAGGGAAACCGTGAATTTTTAAATGAGATAGGCATGATATCTTGTTTGCAACACCCTAATCTTGTGAAACTTCACGGATGTTGCATTGAAGGGGATCAATTAATGTTGGTGTATGAATACATGGAAAATAATAGCCTGGCCCGTGCTTTATTCAGCTTAGAAAATCGGCTTGAACTTGATTGGCCAACAAGGCTTAGGATCATTATTGGCATAGCAAAAGGTCTTGCATTTCTTCATGAAGAATCAAGAATCAAGATTGTTCATCGAGATATCAAAGCTACTAATGTGTTGCTGGATAGGAATTTAAACCCTAAAATATCTGATTTTGGGTTGGCTAAACTTGATGAAGAGGAGAAGACCCATATCATCACCAGAGTGGCTGGGACAATAGGATATATGGCCCCGGAATATGCATTATGGGGTTACCTGACTTACAAGGCTGATGTTTACAGTTTTGGAGTGGTGGTCTTGGAAATTGTTAGTGGGAAGAACAATAACAGTTACATGCCAAGTGATAATTGTGTTTGCCTTTTAGATAGGGCATGCCATTTGCAACGTACTGAAAACTTGAAGAAACTGGTTGATGGAAGGTTGGGATCAGAGGTGAACCCAACTGAAGCAATAAATGTGGTGAGAGTAGCTCTCCTGTGCACAAATGCATCACCTTCACTTAGGCCAACAATGTCTGAGGTTGTAAACATGCTTGAAGGAAGAATGAACATTCCAGATGCTATCCCAGAATCAAGTGTTTCCAGTGAAGATTTAAGGTTTAAAGCCATGAGGGACATCCATCAACACAGGGAAGGTCAGAGTTTGAGCACAAGTGGAACAGACAATTCAACAGGACTCCTTACACGTAGTTCTCCCTCAGTATTTGGCAATGACATACGTGAGATATCCACAGAATCATGA | 3042 | 0.3922 | MLLSRTFFAFLIIALSYCFTWLEYAESKLPQEEVNALEEITRTMGATYWKFDSDSCQIEMVGLTPKRPDGSQSSIDCDCSSEKDTFCHVVRIMFKGYNLPGMLPPEMVKLPYLREIDLALNYLNGTIPKEWASMKLTSISLFVNRLSGEIPKELGNITTLTYLNLEANQFSGLVPSELGSLFDLQTLILSSNKLSGNLPVTFAQLQNLTDFRINDNSFKGKIPSFIQNWKQLQRLEMLGSGLEGPIPSNISLLSNLSQLRISDINGPSQDFPILSNMTGMIRLILRNCNITGELPSYFWTMKSLEMLDLSFNNLVGEIPVTVMVHVGHLRFLFLTGNMLSGNVPDSVLMDGSNVDLSYNNFTWQGAEQSACGDYLNLNLNLFRSSVGTNALQGILPCLKTFNCPRYSSCLHVNCGGKDIKVTENDEDVLYVGDGDVVGGAAKYFNDYKNYWGFSSTGDFLDDGDYQNTRYTRSLSSSSMPELYTTARVSPISLTYFHYCLENGKYTVNLHFAEIQFTNDNTYKSLGKRVFDIYVQERLVWKDFNIEDETHVAQKLRIISIYNVTVTDNILEIRFYWAGKGTTRIPVAGVYGPLISAFSVVSDSKPCSDRTNGRRKIIVGVGFGVGALCLVIIVVGICWWKGYIKGIIRREKGIEGQESHMRTFTLKQISTATDDFSPANKIGEGGFGPVYKGQLSDGTWVAVKQLSSKSRQGNREFLNEIGMISCLQHPNLVKLHGCCIEGDQLMLVYEYMENNSLARALFSLENRLELDWPTRLRIIIGIAKGLAFLHEESRIKIVHRDIKATNVLLDRNLNPKISDFGLAKLDEEEKTHIITRVAGTIGYMAPEYALWGYLTYKADVYSFGVVVLEIVSGKNNNSYMPSDNCVCLLDRACHLQRTENLKKLVDGRLGSEVNPTEAINVVRVALLCTNASPSLRPTMSEVVNMLEGRMNIPDAIPESSVSSEDLRFKAMRDIHQHREGQSLSTSGTDNSTGLLTRSSPSVFGNDIREISTES* | 1014 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Rops2g01155 | 1013 | FunFam | Putative LRR receptor-like serine/threonine-protein kinase isoform A | 199 | 265 | - | - | |
Rops2g01155 | 1013 | Gene3D | - | 407 | 604 | - | - | |
Rops2g01155 | 1013 | SMART | serkin_6 | 675 | 945 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Rops2g01155 | 1013 | ProSiteProfiles | Protein kinase domain profile. | 675 | 949 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Rops2g01155 | 1013 | Pfam | Malectin domain | 409 | 597 | IPR021720 | - | |
Rops2g01155 | 1013 | PANTHER | LEUCINE-RICH REPEAT-CONTAINING PROTEIN DDB_G0281931-RELATED | 15 | 980 | - | - | |
Rops2g01155 | 1013 | Gene3D | Phosphorylase Kinase; domain 1 | 645 | 750 | - | - | |
Rops2g01155 | 1013 | SUPERFAMILY | Protein kinase-like (PK-like) | 657 | 948 | IPR011009 | - | |
Rops2g01155 | 1013 | SUPERFAMILY | L domain-like | 75 | 345 | - | - | |
Rops2g01155 | 1013 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 796 | 808 | IPR008271 | GO:0004672|GO:0006468 | |
Rops2g01155 | 1013 | FunFam | Putative leucine-rich repeat receptor-like serine/threonine-protein kinase | 407 | 602 | - | - | |
Rops2g01155 | 1013 | MobiDBLite | consensus disorder prediction | 975 | 1013 | - | - | |
Rops2g01155 | 1013 | FunFam | probable LRR receptor-like serine/threonine-protein kinase At1g53430 | 645 | 750 | - | - | |
Rops2g01155 | 1013 | FunFam | Probable LRR receptor-like serine/threonine-protein kinase RFK1 | 267 | 390 | - | - | |
Rops2g01155 | 1013 | MobiDBLite | consensus disorder prediction | 979 | 1013 | - | - | |
Rops2g01155 | 1013 | Gene3D | Transferase(Phosphotransferase) domain 1 | 751 | 958 | - | - | |
Rops2g01155 | 1013 | Pfam | Protein tyrosine and serine/threonine kinase | 679 | 945 | IPR001245 | GO:0004672|GO:0006468 | |
Rops2g01155 | 1013 | Gene3D | Ribonuclease Inhibitor | 269 | 371 | IPR032675 | - | |
Rops2g01155 | 1013 | Gene3D | Ribonuclease Inhibitor | 35 | 197 | IPR032675 | - | |
Rops2g01155 | 1013 | Gene3D | Ribonuclease Inhibitor | 198 | 268 | IPR032675 | - | |
Rops2g01155 | 1013 | FunFam | Probable LRR receptor-like serine/threonine-protein kinase RFK1 | 35 | 198 | - | - | |
Rops2g01155 | 1013 | CDD | STKc_IRAK | 681 | 947 | - | - | |
Rops2g01155 | 1013 | FunFam | Putative LRR receptor-like serine/threonine-protein kinase | 751 | 957 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Rops2g01155 | Rops-Chr2 | 16468805 | 16482273 | Dispersed/Proximal |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Rops2g01155 | 8 | 840 | Receptor kinase-like Gene Family | AT1G29750 | 61.391 | 0.0 | 1040 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_DLSV | Rops2g01155 | PK_Tyr_Ser-Thr | 9e-49 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Rops2g01155 | - | - | mtr:11406167 | 1670.6 |